Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers.
Target Price
The average target price of TELA is 3.2 and suggests 327% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell